Market revenue in 2023 | USD 23.5 million |
Market revenue in 2030 | USD 30.5 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Ridt |
Fastest growing segment | RIDT |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | RIDT, RT-PCR, Cell Culture |
Key market players worldwide | 3M Co, Abbott Laboratories, Becton Dickinson & Co, Meridian Bioscience, QuidelOrtho Corp, Roche Holding AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific Inc, Hologic Inc, SA Scientific |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza diagnostics market will help companies and investors design strategic landscapes.
Ridt was the largest segment with a revenue share of 31.06% in 2023. Horizon Databook has segmented the Mexico influenza diagnostics market based on ridt, rt-pcr, cell culture covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico influenza diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico influenza diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account